VRK1 KO resulted in a significant decrease in cell fitness approximately 8 days following viral transduction in neuroblastoma NB-1 cells (Figure 1D), as well as in a larger panel of NB and GBM cell models (Figure 1E). The gene discussed is VRK1; the disease is glioblastoma.